Symbols / BGMS Stock $0.96 +0.37% Bio Green Med Solution, Inc.
BGMS (Stock) Chart
Stock Fundamentals
|
|
|
|
|
|
About
Official websiteBio Green Med Solution, Inc. engages in the distributing, trading, and installation of protective and fire safety materials and equipment, and fire protection and prevention systems. It is also involved in research and development of pharmaceuticals. The company was formerly known as Cyclacel Pharmaceuticals, Inc. and changed its name to Bio Green Med Solution, Inc. in September 2022. Bio Green Med Solution, Inc. was founded in 1996 and is headquartered in Kuala Lumpur, Malaysia.
Ratings
- BGMS Stock Price, Quote & Chart | BIO GREEN MED SOLUTION INC (NASDAQ:BGMS) - ChartMill Fri, 15 May 2026 07
- Bio Green Med (NASDAQ: BGMS) Q1 2026 fire-safety results and going concern warning - Stock Titan Fri, 15 May 2026 20
- symbol__ Stock Quote Price and Forecast - CNN ue, 16 Sep 2025 11
- BIO GREEN MED SOLUTION REPORTS FIRST QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE - Yahoo Finance Singapore hu, 14 May 2026 20
- Bio Green Med Solution Reports First-Quarter 2026 Results - TipRanks hu, 14 May 2026 22
- Fire safety pivot brings $0.8M sales for Bio Green Med, cash into Q4 2026 - Stock Titan hu, 14 May 2026 20
- Bio Green Med Solution, Inc. - Common Stock (NQ: BGMS - FinancialContent Fri, 15 May 2026 20
- What is the current Price Target and Forecast for Bio Green Med Solution, Inc. (BGMS) - Zacks Investment Research Wed, 17 Sep 2025 21
- Bio Green Med Solution, Inc. Completes Acquisition of Fitters Sdn. Bhd. to Diversify Business Portfolio - Quiver Quantitative Fri, 12 Sep 2025 07
- BGMS Stock Price and Chart — NASDAQ:BGMS - TradingView Fri, 12 Sep 2025 15
- BGMS Stock Chart | BIO GREEN MED SOLUTION INC (NASDAQ:BGMS) - ChartMill Fri, 10 Oct 2025 08
- Bio Green Med (NASDAQ: BGMS) logs Q1 loss but slashes expenses in fire safety pivot - Stock Titan hu, 14 May 2026 20
- Bio Green Med Solution Received Notice of Delisting - TradingView Fri, 13 Mar 2026 07
- BIO GREEN MED SOLUTION - BGMS 6 PERP (BGMSP) Stock Price & Overview - ChartMill Fri, 10 Oct 2025 12
- [SCHEDULE 13G/A] Bio Green Med Solution, Inc. Amended Passive Investment Disclosure - Stock Titan ue, 12 May 2026 21
Insider Transactions
Financials
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
0.75
+1637.21%
|
0.04
-89.76%
|
0.42
|
0.00
|
| Operating Revenue |
|
0.75
+1637.21%
|
0.04
-89.76%
|
0.42
|
0.00
|
| Cost Of Revenue |
|
0.61
|
0.00
|
—
|
—
|
| Reconciled Cost Of Revenue |
|
0.61
|
0.00
|
—
|
—
|
| Gross Profit |
|
0.14
+220.93%
|
0.04
|
—
|
—
|
| Operating Expense |
|
8.56
-28.90%
|
12.05
-53.44%
|
25.87
-6.45%
|
27.66
|
| Research And Development |
|
0.85
-87.26%
|
6.66
-65.26%
|
19.16
-5.52%
|
20.27
|
| Selling General And Administration |
|
7.72
+43.12%
|
5.39
-19.74%
|
6.72
-8.99%
|
7.38
|
| General And Administrative Expense |
|
7.72
+43.12%
|
5.39
-19.74%
|
6.72
-8.99%
|
7.38
|
| Other Gand A |
|
7.72
+43.12%
|
5.39
-19.74%
|
6.72
-8.99%
|
7.38
|
| Total Expenses |
|
9.17
-23.85%
|
12.05
-53.44%
|
25.87
-6.45%
|
27.66
|
| Operating Income |
|
-8.43
+29.80%
|
-12.00
+52.84%
|
-25.45
+7.97%
|
-27.66
|
| Total Operating Income As Reported |
|
-8.43
+29.80%
|
-12.00
+52.84%
|
-25.45
+7.97%
|
-27.66
|
| EBITDA |
|
-8.42
+29.80%
|
-12.00
+52.80%
|
-25.42
+7.97%
|
-27.62
|
| Normalized EBITDA |
|
-13.44
-12.54%
|
-11.94
+52.24%
|
-25.01
+10.23%
|
-27.86
|
| Reconciled Depreciation |
|
0.01
-16.67%
|
0.01
-80.65%
|
0.03
-3.13%
|
0.03
|
| EBIT |
|
-8.43
+29.80%
|
-12.00
+52.84%
|
-25.45
+7.97%
|
-27.66
|
| Total Unusual Items |
|
5.02
+9396.30%
|
-0.05
+86.96%
|
-0.41
-277.68%
|
0.23
|
| Total Unusual Items Excluding Goodwill |
|
5.02
+9396.30%
|
-0.05
+86.96%
|
-0.41
-277.68%
|
0.23
|
| Special Income Charges |
|
4.95
|
0.00
|
—
|
—
|
| Net Income |
|
—
|
—
|
—
|
—
|
| Pretax Income |
|
-2.99
+75.06%
|
-11.99
+53.06%
|
-25.55
+1.40%
|
-25.91
|
| Net Non Operating Interest Income Expense |
|
0.06
+416.67%
|
0.01
-95.49%
|
0.27
+26.67%
|
0.21
|
| Net Interest Income |
|
0.06
+416.67%
|
0.01
-95.49%
|
0.27
+26.67%
|
0.21
|
| Interest Income Non Operating |
|
0.06
+416.67%
|
0.01
-95.49%
|
0.27
+26.67%
|
0.21
|
| Interest Income |
|
0.06
+416.67%
|
0.01
-95.49%
|
0.27
+26.67%
|
0.21
|
| Other Income Expense |
|
5.37
+268800.00%
|
-0.00
+99.45%
|
-0.36
-123.78%
|
1.53
|
| Other Non Operating Income Expenses |
|
0.35
+580.77%
|
0.05
+4.00%
|
0.05
-96.15%
|
1.30
|
| Gain On Sale Of Security |
|
0.07
+235.19%
|
-0.05
+86.96%
|
-0.41
-277.68%
|
0.23
|
| Gain On Sale Of Business |
|
4.95
|
0.00
|
—
|
—
|
| Tax Provision |
|
0.01
+100.90%
|
-0.78
+73.90%
|
-3.00
+36.49%
|
-4.72
|
| Tax Rate For Calcs |
|
0.00
+268.10%
|
0.00
-44.40%
|
0.00
-35.58%
|
0.00
|
| Tax Effect Of Unusual Items |
|
1.20
+34319.88%
|
-0.00
+92.75%
|
-0.05
-214.46%
|
0.04
|
| Net Income Including Noncontrolling Interests |
|
-3.00
+73.26%
|
-11.21
+50.29%
|
-22.55
-6.40%
|
-21.20
|
| Net Income From Continuing Operation Net Minority Interest |
|
-3.00
+73.26%
|
-11.21
+50.29%
|
-22.55
-6.40%
|
-21.20
|
| Net Income From Continuing And Discontinued Operation |
|
-3.00
+73.26%
|
-11.21
+50.29%
|
-22.55
-6.40%
|
-21.20
|
| Net Income Continuous Operations |
|
-3.00
+73.26%
|
-11.21
+50.29%
|
-22.55
-6.40%
|
-21.20
|
| Normalized Income |
|
-6.81
+38.96%
|
-11.16
+49.70%
|
-22.19
-3.74%
|
-21.39
|
| Net Income Common Stockholders |
|
-14.09
-25.69%
|
-11.21
+50.73%
|
-22.76
-6.34%
|
-21.40
|
| Otherunder Preferred Stock Dividend |
|
11.03
|
0.00
|
—
|
0.00
|
| Diluted EPS |
|
-6.45
+98.71%
|
-501.60
+92.19%
|
-6,420.00
+6.14%
|
-6,840.00
|
| Basic EPS |
|
-6.45
+98.71%
|
-501.60
+92.19%
|
-6,420.00
+6.14%
|
-6,840.00
|
| Basic Average Shares |
|
2.19
+5819.53%
|
0.04
+941.27%
|
0.00
+13.40%
|
0.00
|
| Diluted Average Shares |
|
2.19
+5819.53%
|
0.04
+941.27%
|
0.00
+13.40%
|
0.00
|
| Diluted NI Availto Com Stockholders |
|
-14.09
-25.69%
|
-11.21
+50.73%
|
-22.76
-6.34%
|
-21.40
|
| Preferred Stock Dividends |
|
0.06
|
—
|
0.20
+0.00%
|
0.20
|
| Line Item | Trend | 2023-12-31 |
|---|---|---|
| Total Assets |
|
8.80
|
| Current Assets |
|
7.44
|
| Cash Cash Equivalents And Short Term Investments |
|
3.38
|
| Cash And Cash Equivalents |
|
3.38
|
| Cash Equivalents |
|
0.07
|
| Cash Financial |
|
3.30
|
| Receivables |
|
3.73
|
| Accounts Receivable |
|
—
|
| Gross Accounts Receivable |
|
—
|
| Allowance For Doubtful Accounts Receivable |
|
—
|
| Taxes Receivable |
|
3.73
|
| Inventory |
|
—
|
| Raw Materials |
|
—
|
| Work In Process |
|
—
|
| Finished Goods |
|
—
|
| Prepaid Assets |
|
—
|
| Other Current Assets |
|
0.34
|
| Total Non Current Assets |
|
1.36
|
| Net PPE |
|
0.10
|
| Gross PPE |
|
0.52
|
| Accumulated Depreciation |
|
-0.42
|
| Properties |
|
0.00
|
| Machinery Furniture Equipment |
|
0.42
|
| Other Properties |
|
0.09
|
| Leases |
|
0.01
|
| Goodwill And Other Intangible Assets |
|
—
|
| Goodwill |
|
—
|
| Non Current Prepaid Assets |
|
1.26
|
| Total Liabilities Net Minority Interest |
|
8.20
|
| Current Liabilities |
|
8.16
|
| Payables And Accrued Expenses |
|
7.78
|
| Payables |
|
3.54
|
| Accounts Payable |
|
3.54
|
| Current Accrued Expenses |
|
4.24
|
| Other Current Liabilities |
|
0.38
|
| Total Non Current Liabilities Net Minority Interest |
|
0.04
|
| Long Term Debt And Capital Lease Obligation |
|
0.04
|
| Long Term Capital Lease Obligation |
|
0.04
|
| Other Non Current Liabilities |
|
—
|
| Stockholders Equity |
|
0.61
|
| Common Stock Equity |
|
0.61
|
| Capital Stock |
|
0.00
|
| Common Stock |
|
0.00
|
| Preferred Stock |
|
0.00
|
| Share Issued |
|
0.00
|
| Ordinary Shares Number |
|
0.00
|
| Treasury Shares Number |
|
0.00
|
| Additional Paid In Capital |
|
429.80
|
| Retained Earnings |
|
-428.28
|
| Gains Losses Not Affecting Retained Earnings |
|
-0.91
|
| Other Equity Adjustments |
|
-0.91
|
| Total Equity Gross Minority Interest |
|
0.61
|
| Total Capitalization |
|
0.61
|
| Working Capital |
|
-0.72
|
| Invested Capital |
|
0.61
|
| Total Debt |
|
0.04
|
| Capital Lease Obligations |
|
0.04
|
| Net Tangible Assets |
|
0.61
|
| Tangible Book Value |
|
0.61
|
| Preferred Shares Number |
|
0.34
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-4.77
+40.30%
|
-7.99
+50.41%
|
-16.11
+22.64%
|
-20.83
|
| Cash Flow From Continuing Operating Activities |
|
-4.77
+40.30%
|
-7.99
+50.41%
|
-16.11
+22.64%
|
-20.83
|
| Net Income From Continuing Operations |
|
-3.00
+73.26%
|
-11.21
+50.29%
|
-22.55
-6.40%
|
-21.20
|
| Depreciation Amortization Depletion |
|
0.01
-16.67%
|
0.01
-80.65%
|
0.03
-3.13%
|
0.03
|
| Depreciation |
|
0.01
-16.67%
|
0.01
-80.65%
|
0.03
-3.13%
|
0.03
|
| Depreciation And Amortization |
|
0.01
-16.67%
|
0.01
-80.65%
|
0.03
-3.13%
|
0.03
|
| Other Non Cash Items |
|
0.00
+105.41%
|
-0.04
+46.38%
|
-0.07
|
—
|
| Stock Based Compensation |
|
2.33
+294.26%
|
0.59
-59.81%
|
1.47
-2.19%
|
1.51
|
| Operating Gains Losses |
|
4.95
|
—
|
—
|
—
|
| Change In Working Capital |
|
-9.06
-440.47%
|
2.66
-46.87%
|
5.01
+529.13%
|
-1.17
|
| Change In Receivables |
|
-1.26
|
0.00
|
—
|
—
|
| Changes In Account Receivables |
|
-1.26
|
0.00
|
—
|
—
|
| Change In Inventory |
|
-1.38
|
0.00
|
—
|
—
|
| Change In Prepaid Assets |
|
4.09
-8.61%
|
4.47
-5.09%
|
4.71
+224.52%
|
-3.78
|
| Change In Payables And Accrued Expense |
|
-10.51
-480.12%
|
-1.81
-711.82%
|
0.30
-88.51%
|
2.58
|
| Change In Payable |
|
-10.51
-480.12%
|
-1.81
-711.82%
|
0.30
-88.51%
|
2.58
|
| Change In Account Payable |
|
-10.51
-480.12%
|
-1.81
-711.82%
|
0.30
-88.51%
|
2.58
|
| Change In Other Current Liabilities |
|
—
|
-0.04
+46.38%
|
-0.07
-272.50%
|
0.04
|
| Investing Cash Flow |
|
0.00
|
0.00
+100.00%
|
-0.01
+14.29%
|
-0.01
|
| Cash Flow From Continuing Investing Activities |
|
0.00
|
0.00
+100.00%
|
-0.01
+14.29%
|
-0.01
|
| Net PPE Purchase And Sale |
|
0.00
|
0.00
+100.00%
|
-0.01
+14.29%
|
-0.01
|
| Purchase Of PPE |
|
0.00
|
0.00
+100.00%
|
-0.01
+14.29%
|
-0.01
|
| Capital Expenditure |
|
—
|
—
|
-0.01
+14.29%
|
-0.01
|
| Gain Loss On Sale Of Business |
|
4.95
|
0.00
|
—
|
—
|
| Financing Cash Flow |
|
5.26
-32.70%
|
7.82
+822.41%
|
0.85
-71.71%
|
3.00
|
| Cash Flow From Continuing Financing Activities |
|
5.26
-32.70%
|
7.82
+822.41%
|
0.85
-71.71%
|
3.00
|
| Net Common Stock Issuance |
|
6.42
+3.48%
|
6.21
+491.90%
|
1.05
-67.21%
|
3.20
|
| Cash Dividends Paid |
|
-0.06
|
0.00
+100.00%
|
-0.20
+0.00%
|
-0.20
|
| Proceeds From Stock Option Exercised |
|
0.00
-100.00%
|
1.61
|
0.00
|
0.00
|
| Net Other Financing Charges |
|
-1.10
|
—
|
—
|
—
|
| Changes In Cash |
|
0.49
+394.05%
|
-0.17
+98.90%
|
-15.27
+14.39%
|
-17.84
|
| Effect Of Exchange Rate Changes |
|
-0.13
-72.60%
|
-0.07
-124.09%
|
0.30
+180.16%
|
-0.38
|
| Beginning Cash Position |
|
3.14
-7.13%
|
3.38
-81.59%
|
18.34
-49.82%
|
36.56
|
| End Cash Position |
|
3.50
+11.73%
|
3.14
-7.13%
|
3.38
-81.59%
|
18.34
|
| Free Cash Flow |
|
-4.77
+40.30%
|
-7.99
+50.43%
|
-16.12
+22.64%
|
-20.83
|
| Interest Paid Supplemental Data |
|
0.01
|
0.00
|
—
|
—
|
| Income Tax Paid Supplemental Data |
|
0.02
+800.00%
|
0.00
+0.00%
|
0.00
+0.00%
|
0.00
|
| Common Stock Issuance |
|
6.42
+3.48%
|
6.21
+491.90%
|
1.05
-67.21%
|
3.20
|
| Issuance Of Capital Stock |
|
6.42
+3.48%
|
6.21
+491.90%
|
1.05
-67.21%
|
3.20
|
| Preferred Stock Dividend Paid |
|
-0.06
|
0.00
+100.00%
|
-0.20
+0.00%
|
-0.20
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 10-Q2026-05-15 View
- 8-K2026-05-14 View
- 8-K2026-04-13 View
- 10-K2026-03-30 View
- 8-K2026-03-30 View
- 8-K2026-03-13 View
- 8-K2026-01-12 View
- 42025-11-13 View
- 42025-11-13 View
- 10-Q2025-11-13 View
- 8-K2025-11-13 View
- 8-K2025-11-06 View
- 42025-11-05 View
- 42025-11-05 View
- 42025-11-05 View
- 42025-11-03 View
- 42025-11-03 View
- 42025-11-03 View
- 42025-10-31 View
- 42025-10-30 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|